z-logo
open-access-imgOpen Access
Long non-coding RNA CCAT1 is overexpressed in oral squamous cell carcinomas and predicts poor prognosis
Author(s) -
Ganesan Arunkumar,
Avaniyapuram Kannan Murugan,
Harikrishnan Prasanna Srinivasa Rao,
Subbiah Shanmugam,
Ramamurthy Rajaraman,
Arasambattu Kannan Munirajan
Publication year - 2017
Publication title -
biomedical reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.607
H-Index - 25
eISSN - 2049-9442
pISSN - 2049-9434
DOI - 10.3892/br.2017.876
Subject(s) - carcinogenesis , oncogene , long non coding rna , cancer research , molecular medicine , cancer , basal cell , cell , colorectal cancer , medicine , biology , gene , oncology , rna , cell cycle , genetics
Oral squamous cell carcinoma (SCC) is the most common malignant tumor in India with 5-year survival rates totaling <50%. Recently, dysregulation of non-coding RNA was reported as a potential hallmark of carcinogenesis. Colon Cancer Associated Transcript 1 (CCAT1), an lncRNA located in chromosome 8q24, close to the c-Myc gene, has been reported to be overexpressed in many human cancers. In the present study, the authors analyzed the expression of CCAT1, c-Myc and the miRNAs miR155-5p, let7b-5p, miR490-3p and miR218-5p sponged by CCAT1 in 60 oral tumor and 8 normal tissue samples by reverse transcription-quantitative polymerase chain reaction. CCAT1 was significantly overexpressed in 27% (16/60) of oral tumors. Interestingly, a high level of c-Myc expression was observed in all CCAT1 overexpressing cases (P=0.0473). Furthermore, CCAT1 overexpression significantly downregulated miR155-5p (P=0.03) and let7b-5p (P<0.0001). Oral cancer cases expressing high level of CCAT1 (P=0.01) presented poor therapeutic outcome. To the best of the authors' knowledge, this is the first study to report the overexpression of the CCAT1 in oral SCCs, and the results suggested that CCAT1 overexpression may sponge miR155-5p and let7b-5p, and may account for poor treatment response.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here